Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study
Molly Brewer, Roberto Angioli, Giovanni Scambia, Domenica Lorusso, Corrado Terranova, Pierluigi Benedetti Panici, Francesco Raspagliesi, Paolo Scollo, Francessco Plotti, Maria Gabriella Ferrandina, Vanda Salutari, Caterina Ricci, Patricia Braly, Robert Holloway, Michael Method, Madi Madiyalakan, Eliel Bayever, Christopher Nicodemus
Entra nei temi di ricerca di 'Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study'. Insieme formano una fingerprint unica.